IPOScoop

Anthropic (ANT Proposed), known for its Claude AI platform, launched its $61.05 billion IPO today – Tuesday, Nov. 10, 2026 – after disclosing its terms: 825 million shares at a price range of $70.00 to $78.00 a share to raise $61.05 billion, if priced at the $74.00 mid-point of its range. At pricing, Anthropic would have a market cap of $968.44 billion – just...

Windward Bio (WWB Proposed), a Swiss biotech developing long-acting drug candidates to treat asthma, COPD and atopic dermatitis, unveiled the terms early today (Monday, Nov. 9,2026) for its $175 million IPO. Windward Bio is offering 10.29 million shares at a price range of $16.00 to $18.00 to raise $174.93 million, if priced at the $17.00 mid-point of its range, accor...

Two healthcare IPOs – Rezera (RZRA Proposed), a biotech targeting peripheral artery disease (PAD), and vVardis Holding AG

vVardis Holding AG (VVVV Proposed), a dental products start-up backed by Apollo, launched its $214.3 million IPO on Friday afternoon – Nov. 6, 2026. The deal is set to price next week. vVardis, based in Zug, Switzerland, is offering 9.52 million shares at a price ra...

Rezera Inc. (RZRA Proposed), a Boston biotech planning a Phase 3 trial in 2027 of its leading drug candidate to treat peripheral artery disease (PAD), unveiled the terms for its $200 million IPO early today – Thursday, Nov. 5, 2026 – in an S-1/A filing. Reze...